¼¼°èÀÇ ºÐÀÚ Ç°Áú°ü¸® ½ÃÀå ¿¹Ãø(-2028³â) : Á¦Ç° À¯Çüº°, ¿ëµµº°, °Ëü À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Molecular Quality Controls Market Product (Independent Control, Instrument Specific Control ), Application (Infectious Disease Diagnostics), Analyte type, End User (Hospitals, Diagnostic Lab), Region- Global Forecast to 2028
»óǰÄÚµå : 1310547
¸®¼­Ä¡»ç : MarketsandMarkets
¹ßÇàÀÏ : 2023³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 282 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,817,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,650 £Ü 9,158,000
PDF (5-user License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,150 £Ü 11,224,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,772,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. (100% ÀÚȸ»ç´Â µ¿ÀÏ ±â¾÷À¸·Î °£Áֵ˴ϴÙ.) Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ºÐÀÚ Ç°Áú°ü¸® ½ÃÀå ±Ô¸ð´Â 2023³â 2¾ï ´Þ·¯¿¡¼­ 2028³â±îÁö 3¾ï ´Þ·¯¿¡ ´ÞÇϸç, ¿¹Ãø ±â°£ Áß CAGR·Î 6.6%ÀÇ ¼ºÀåÀÌ ¿¹ÃøµË´Ï´Ù.

½ÃÀåÀÇ ¼ºÀåÀº ÁÖ·Î °Ô³ð ÇÁ·ÎÁ§Æ®¿¡ ´ëÇÑ Á¤ºÎÀÇ ÀÚ±Ý Á¦°ø Áõ°¡ ¹× ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿äÀÇ Áõ°¡, ½ÃÄö½Ì ½Ã¼úÀÇ ºñ¿ë Ç϶ô, °¨¿°Áõ, ¾Ï, À¯Àü¼º ÁúȯÀÇ À¯Çà¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ǰÁú°ü¸® ÇÁ·Î¼¼½º¿¡ ¼ö¹ÝÇÏ´Â Ãß°¡ ºñ¿ë ¹× º´¿ø°ú ¿¬±¸¼Ò¿¡¼­ÀÇ ¿¹»ê Á¦¾à, ºÐÀÚ °Ë»ç¿¡ ´ëÇÑ ºÒ¸®ÇÑ »óȯ ½Ã³ª¸®¿À°¡ ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦ÇÒ °ÍÀ¸·Î Àü¸ÁµÇ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

µ¶¸³ °ü¸® ºÎ¹®ÀÌ ¿¹Ãø ±â°£ Áß ½ÃÀå¿¡¼­ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÒ Àü¸ÁÀÔ´Ï´Ù.

Á¦Ç°º°·Î ½ÃÀåÀº µ¶¸³ °ü¸®¿Í ±â±¸ °íÀ¯ °ü¸®·Î ±¸ºÐµË´Ï´Ù. 2022³â ¼¼°èÀÇ ºÐÀÚ Ç°Áú°ü¸® ½ÃÀå¿¡¼­´Â µ¶¸³ °ü¸® ºÎ¹®ÀÌ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¼­µåÆÄƼ µ¶¸³ °ü¸®ÀÇ ÀÌ¿ë Áõ°¡°¡ ÀÌ ºÎ¹®ÀÇ Å« Á¡À¯À² ¿äÀÎÀÔ´Ï´Ù.

´ÜÀÏ °Ëü °ü¸®°¡ ¿¹Ãø ±â°£ Áß ½ÃÀå¿¡¼­ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÒ Àü¸ÁÀÔ´Ï´Ù.

°Ëü À¯Çüº°·Î ½ÃÀåÀº ´ÜÀÏ °Ëü °ü¸®¿Í º¹¼ö °Ëü °ü¸®·Î ±¸ºÐµË´Ï´Ù. ´ÜÀÏ °Ëü °ü¸®´Â 2022³â ºÐÀÚ Ç°Áú°ü¸® ½ÃÀå¿¡¼­ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. º´¿ø¿¡¼­ ½Ì±ÛÇ÷º½º ¾î¼¼ÀÌÀÇ ÇöÀúÇÑ ÀÌ¿ë ¹× ³·Àº ±³Â÷ ¹ÝÀÀ¼ºÀÇ ¸®½ºÅ© µîÀÌ ÀÌ ºÎ¹®ÀÇ Å« Á¡À¯À² ¿äÀÎÀÔ´Ï´Ù.

°¨¿°Áõ Áø´Ü ºÎ¹®ÀÌ 2022³â¿¡ ½ÃÀå¿¡¼­ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

¿ëµµº°·Î ½ÃÀåÀº °¨¿°Áõ Áø´Ü, À¯ÀüÀÚ °Ë»ç, Á¾¾ç °Ë»ç, ±âŸ ¿ëµµ(½Å°æÁúȯ °Ë»ç, DNA ÇΰŠÇÁ¸°ÆÃ, Á¶Á÷ ŸÀÌÇÎ, ¹Ì»ý¹°ÇÐ, ½ÉÇ÷°üÁúȯ °Ë»ç Æ÷ÇÔ)·Î ±¸ºÐµË´Ï´Ù. °¨¿°Áõ Áø´Ü ºÎ¹®Àº 2022³â ¼¼°èÀÇ ºÐÀÚ Ç°Áú°ü¸® ½ÃÀå¿¡¼­ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. °¨¿°ÁõÀÇ À¯º´·ü ´ëÆøÀûÀÎ Áõ°¡°¡ ÀÌ ºÎ¹® Å« Á¡À¯À² ¿äÀÎÀÔ´Ï´Ù.

Áø´Ü ¿¬±¸¼Ò ºÎ¹®Àº 2022³â¿¡ ½ÃÀå¿¡¼­ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚº°·Î ½ÃÀåÀº Çмú¡¤¿¬±¸±â°ü, Áø´Ü ¿¬±¸¼Ò, IVD Á¦Á¶¾÷ü¡¤CRO, º´¿ø, ±âŸ ÃÖÁ¾»ç¿ëÀÚ(ÀçÅÃÀÇ·á ±â°ü, Ç÷¾×ÀºÇà, ³Ê½ÌȨ, Áö¿ªÀÇ °øÁߺ¸°Ç ¿¬±¸¼Ò)·Î ±¸ºÐµË´Ï´Ù. Áø´Ü ¿¬±¸¼Ò ºÎ¹®ÀÌ 2022³â¿¡ ºÐÀÚ Ç°Áú°ü¸® ½ÃÀå¿¡¼­ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. Áø´Ü ¿¬±¸¼Ò¿¡¼­ ½ÃÇàµÇ´Â ÀÓ»ó °Ë»ç ¼öÀÇ Áõ°¡°¡ ÀÌ ºÎ¹®ÀÇ Å« Á¡À¯À² ¿äÀÎÀÔ´Ï´Ù.

ºÏ¹Ì°¡ 2022³â ºÐÀÚ Ç°Áú°ü¸® ½ÃÀå¿¡¼­ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

Áö¿ªº°·Î ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«·Î ±¸ºÐµË´Ï´Ù. ºÏ¹Ì´Â 2022³â¿¡ ºÐÀÚ Ç°Áú°ü¸® ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. ÀÌ Áö¿ª ºÎ¹®ÀÌ Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ´Â °ÍÀº ÁÖ·Î ¹Ì±¹°ú ij³ª´Ù¿¡¼­ ÀÇ·á ½Ã½ºÅÛÀÌ ¹ß´ÞÇϰí ÀÖ´Â °Í ¹× ºÐÀÚ Ç°Áú°ü¸® Á¦Ç°ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü°¡ ´Ù¼ö Á¸ÀçÇÏ´Â °Í, ºÏ¹Ì¿¡¼­ ÷´Ü ±â¼ú Á¦Ç°ÀÌ ¿ëÀÌÇÏ°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ´Â °Í µî¿¡ ±âÀÎÇÕ´Ï´Ù.

¼¼°èÀÇ ºÐÀÚ Ç°Áú°ü¸® ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ¿ªÇÐ, Áö¿ª°ú ºÎ¹® ºÐ¼®, ±â¾÷ °³¿ä µîÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ÁÖ¿ä ÀλçÀÌÆ®

Á¦5Àå ½ÃÀåÀÇ °³¿ä

Á¦6Àå ºÐÀÚ Ç°Áú°ü¸® ½ÃÀå : Á¦Ç°º°

Á¦7Àå ºÐÀÚ Ç°Áú°ü¸® ½ÃÀå : °Ëü À¯Çüº°

Á¦8Àå ºÐÀÚ Ç°Áú°ü¸® ½ÃÀå : ¿ëµµº°

Á¦9Àå ºÐÀÚ Ç°Áú°ü¸® ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ºÐÀÚ Ç°Áú°ü¸® ½ÃÀå : Áö¿ªº°

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå ±â¾÷ °³¿ä

Á¦13Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global molecular quality controls market is projected to reach USD 0.3 billion by 2028 from USD 0.2 billion in 2023, at a CAGR of 6.6% during the forecast period. Growth in this market is primarily driven by the increasing government funding for genomic projects, increasing demand for personalized medicines and declining costs of sequencing procedures, and increasing prevalence of infectious diseases, cancer, and genetic diseases. However, the additional costs involved in the quality control process and budget constraints in hospitals and laboratories, and the unfavorable reimbursement scenario for molecular tests are the major factors that are expected to restrain the growth of this market during the forecast period.

The independent controls segment has accounted for the biggest share of the market during the forecast period

By product, the molecular quality controls market is segmented into independent controls and instrument-specific controls. The independent controls segment accounted for the biggest share of the global molecular quality controls market in 2022. The increasing use of third-party independent quality controls is responsible for the large share of this segment.

The single-analyte controls has accounted for the biggest share of the market during the forecast period.

By analyte type, the molecular quality controls market is divided into single-analyte controls and multi-analyte controls. Single-analyte controls accounted for the biggest share of the molecular quality controls market in 2022. Factors such as the significant use of singleplex assays in hospitals, and low risk of cross-reactivity are responsible for the large share of this segment.

The infectious disease diagnostic segment accounted for the biggest share of the market in 2022

By application, the molecular quality controls market is divided into infectious disease diagnostics, genetic testing, oncology testing, and other applications (including neurology disease testing, , DNA fingerprinting, tissue typing, microbiology and cardiovascular disease testing). The infectious disease diagnostics segment accounted for the biggest share of the global molecular quality controls market in 2022. The significant increase in the prevalence of infectious diseases is responsible for the large share of this segment.

The diagnostic laboratories segment accounted for the biggest share of the market in 2022

By end users, the molecular quality controls market is segmented into academic & research institutes, diagnostic laboratories, IVD manufacturers & CROs, hospitals and other end users (home health agencies, blood banks, nursing homes, and local public health laboratories). The diagnostic laboratories segment accounted for the biggest share of the molecular quality controls market in 2022. The growing number of laboratory tests performed in diagnostic laboratories is responsible for the large share of this segment.

North America accounted for the largest share of the Molecular Quality Controls market in 2022

Based on region, the molecular quality controls market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the molecular quality controls market in 2022. The large share of this regional segment is mainly due to the developed healthcare system in the US and Canada, the presence of many leading molecular quality control product manufacturers, and easy accessibility to technologically advanced products in North America.

The break up of the profile of primary participants in the molecular Quality controls market:

Key players in the molecular quality controls market

The key players operating in the molecular quality controls market include Microbiologics, Inc. (US), Steck, Inc. (US), Bio-Rad Laboratories, Inc. (US), Anchor Molecular (US), Thermo Fisher Scientific, Inc. (US), Randox Laboratories Ltd. (UK), LGC Limited (UK), Abbott Laboratories (US), Fortress Diagnostics (UK), SERO AS (Norway), Anchor Molecular (US), Vircell S.L. (Spain), Ortho Clinical Diagnostics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Microbix Biosystems Inc. (Canada), Molbio Diagnostics Pvt. Ltd. (India), QuidelOrthoCorporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix, LLC (US), Qnostics (UK), Bio-Techne Corporation (US), Helena Laboratories Corporation (US), SpeeDx Pty. Ltd. (Australia), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain).

Research Coverage:

The report analyzes the molecular quality controls market and aims at estimating the market size and future growth potential of this market based on various segments such as product, analyte type, application, and end user. The report also includes a product portfolio matrix of various molecular quality controls products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT

7 MOLECULAR QUALITY CONTROL MARKET, BY ANALYTE TYPE

8 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION

9 MOLECULAR QUALITY CONTROLS MARKET, BY END USER

10 MOLECULAR QUALITY CONTROLS MARKET, BY REGION

11 COMPETITIVE LANDSCAPE

12 COMPANY PROFILES

13 APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â